**Charity registration number 1205120 (England and Wales)** 

## **RAREMINDS CIO** 

**ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 



## **RAREMINDS CIO** 

## **LEGAL AND ADMINISTRATIVE INFORMATION** 

|**Trustees**|Paul Stevens||
|---|---|---|
||Rachel Milroy||
||Michael Hartnett||
||Dr Sarah Wynn PhD||
|**Senior management**|Lauren Roberts|Chief Executive Officer|
||Kym Winter|Chief Clinical Officer|
||Catherine Sleath|Head of Operations|
|**Charity registration**|England and Wales|1205120|
|**Registered address**|86 - 90 Paul Street||
||London||
||EC2A 4NE||
|**Independent examiner**|Gary Howard FCA||
||Howard Wilson Chartered Accountants||
||36 Crown Rise||
||Watford||
||Hertfordshire||
||WD25 0NE||
|**Bankers**|The Co-operative Bank plc||
||1 Balloon Street||
||Manchester||
||M60 4EP||





## **RAREMINDS CIO** 

## **CONTENTS** 

||**Page**|
|---|---|
|Trustees' report|1 - 4|
|Statement of trustees' responsibilities|5|
|Independent examiner's report|6|
|Statement of financial activities|7 - 8|
|Balance sheet|9|
|Notes to the financial statements|10 - 18|





## **RAREMINDS CIO** 

## **TRUSTEES' REPORT** 

## _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

The trustees present their annual report and financial statements for the year ended 31 December 2025. 

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". 

## **Objectives and activities** 

The charitable objects of the CIO are: 

To promote and protect the mental health of those suffering from the impact of rare diseases for the public benefit throughout the world by: 

- i. the provision of therapeutic counselling and emotional support programmes, 

- ii. raising the awareness of the mental health impact of rare diseases, 

- iii. advancing the education of health and social care professionals about the mental health impact of rare diseases, 

- iv. undertaking research into areas related to the above three objects and publishing the useful results. 

## **Our vision** 

Our vision is that the psychological and emotional impact of living with a rare condition is recognised as an essential part of rare condition care, ensuring everyone has access to high-quality, specialist mental health support. 

## **Our mission** 

Our mission is to provide affordable, timely and expert counselling for the rare disease community.  We also work to raise awareness, inform policy and promote excellence in the recognition and delivery of specialist mental health care. 

## **Our aims** 

- Provide specialist counselling, psychotherapy and wellbeing support. 

- Be a central hub of expertise to inform policy, practice and promote excellence. 

- Campaign for increased awareness and inclusion of mental health in rare disease care 

## _Public benefit_ 

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake and confirms compliance with the guidance on public benefit. 

## **Activities** 

We have worked in partnership with 29 rare condition organisations to provide counselling and well-being services to individuals, couples, families and professionals impacted by rare conditions. 

Our main activities were: 

## **1:1 counselling sessions for individuals and couples** 

Our team of specialist counsellors provided 3,089 counselling sessions for 442 clients. 

## **Therapeutic Group Programmes** 

We facilitated sixteen 8 week Group Programmes for 7 different rare condition organisations with a total of 165 participants. Our Group Programmes aim to ease isolation and build peer support networks. 

## **Workshops and presentations** 

We delivered 13 workshops and presentations on topics like ‘Living with your rare condition’ and ‘Dealing with Diagnosis’ to 13 different rare condition organisations with a total of nearly 200 attendees. 

- 1 - 



## **RAREMINDS CIO** 

## **TRUSTEES' REPORT  (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **Patient Organisation Days and Conferences** 

We attended patient organisation days and conferences, delivered talks and participated in Panels at international events to raise awareness of the psychological impact of living with a rare condition. This included running a workshop on mental health at the Eurordis (Rare Diseases Europe) Membership meeting in Latvia, and a panel discussion on rare conditions and mental health at World Orphan Drug Congress in Amsterdam. 

## **Training for Healthcare Professionals** 

We provided 5 training sessions for Health Care Professionals helping to enable them to support the mental health of their rare condition patients. 

## **Psychoeducational Resources** 

We produced video and written resources for 6 different patient organisations and continued to develop our own online Wellbeing Hub. 

## **Achievements and performance** 

_Significant activities and achievements against objectives_ 

Details of activities and significant charitable achievements against objectives during the year: 

43% (123/347) of Rareminds clients start counselling with a psychological distress level of severe or moderately severe (measured using the clinical evaluation tool CORE-10). 

- 33% of clients starting with a distress level of severe or moderately severe ended counselling with a distress rating of low, mild or healthy. 

57%* (119) Rareminds clients have a psychological distress rating of health or low when they complete a series of counselling. (*Based on clients who completed a start and end CORE-10). 

We received feedback from 161 counselling service clients. They told us: 

- 96% (155 clients) found the counselling sessions helpful or very helpful 

- 84% (135 clients) found their counsellor to be extremely aware of their rare condition 

- 87% (140 clients) found it very helpful/useful that their counsellor was aware of their rare condition 

- 94% (151 clients) felt better able to manage their rare condition after counselling 

- 99% (160 clients) would recommend their counsellor to others. 

## Feedback from clients included: 

_[Counsellor] really is a credit to your service. Just in the way [they] approached every session really made me feel at ease. I do find trusting people hard but it came very easy. [They] gave me great understanding of how my mind worked and why it thinks in a certain way which has helped me become more self aware._ 

_First ever experience with counselling and I am very grateful I had the opportunity to speak to [counsellor], [they have] helped me to feel in a better place with my child’s rare genetic condition, managing my emotions around other family circumstances and childhood experiences, it’s made me more aware of why I am the person I am today and making me think of ways to recognise and managing things in the future, I will return if needed in the future as it’s been very helpful._ 

_[Counsellor] was extremely kind, understanding, helpful and patient; [they] pushed me just enough, and helped me move forwards in my life. [They] gave me good recommendations and ideas of human behaviour patterns, and led me to find my own way into letting go of held in hard emotions, so I no longer feel like a victim in my life._ 

- 2 - 



## **RAREMINDS CIO** 

## **TRUSTEES' REPORT  (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

93% of people who participated in our Autumn 2025 group programme felt that the group facilitator had a good or very good understanding of their rare condition. 

- 80% of participants felt well, or very well, equipped to look after their mental wellbeing after taking part in our group programme (compared to 66% at the start). 

- 82% of participants felt anxious always or often before taking part in our group programme. At the end of the programme, 39% felt anxious always or often. 

91% of group participants would recommend the programme to others. 

_I feel this course helped me move forward with beginning to accept my diagnosis and manage the uncertainty._ 

_I really got so much out of the sessions and would like to emphasise how much I appreciate that I was able to take part, thank you! [Counsellor] is a wonderful facilitator, very calm, helpful and gentle. She made the sessions feel like a secure space where everyone could open up, be themselves and share their experiences without judgement, whilst gently guiding us through the sessions and sharing useful tools and resources._ 

## **Financial review** 

During the year income was £396,527 (2024: £306,653) an increase of £89,874 on the previous period which was a 15 month period. 

Expenditure was £315,686 compared to £276,377 in the 15 month period, an increase of £39,309. 

The charity made a surplus for the year of £80,841 of which there was a surplus of £90,792 on unrestricted funds and a deficit of £9,951 on restricted funds.  In the 15 month period there was a surplus of £30,276 of which there was a surplus of £9,657 on unrestricted funds and a surplus of £20,619 on restricted funds. 

At the year end the charity had reserves to carry forward of £123,277 on unrestricted funds and £10,668 on restricted funds. 

In the process of preparing the accounts for the year ended 31 December 2025 we became aware of a computational error in the accounts for the previous fifteen month period ended 31 December 2024.  The error related to the balance of reserves brought forward at the start of the fifteen month period and resulted in incorrect figures being shown for reserves carried forward at 31 December 2024.  The computational errors in the accounts did not affect the net movement in funds for that period.  The errors have been corrected in the comparative figures shown in these accounts.  The Board considered producing amended accounts for the fifteen month period to submit to the Charity Commission but ultimately decided that, because the errors affected a limited part of the information in those accounts, the time and costs involved in doing this would not be justified. 

## _Reserves policy_ 

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to three month’s operational expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been increased during the year and is now in line with the policy. 

## _Major risks_ 

The trustees have considered the major risks to which the charity is exposed and have established procedures including a risk register to identify and manage those risks. 

- 3 - 



## **RAREMINDS CIO** 

## **TRUSTEES' REPORT  (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **Plans for future periods** 

The charity's plans for future periods include: 

- Launching our next 5 year strategy in 2027 

- New sections of our Wellbeing Hub to provide resources on pain, fatigue and fertility. We will also translate the hub into key European languages. 

- New series of our podcast about mental health and rare conditions. 

- Explore and encourage research into rare conditions and mental health, including social listening as a research tool. 

- Continue to develop and grow our team and expertise. 

## **Structure, governance and management** 

The charity was founded as a Community Interest Company in 2021 and converted to a Charitable Incorporated Organisation (CIO) in 2023.  The CIO was registered as a charity with the Charity Commission for England and Wales on 09 October 2023. 

The trustees who served during the year and up to the date of signature of the financial statements were: Paul Stevens 

Rachel Milroy Michael Hartnett Dr Sarah Wynn PhD 

## _Recruitment and appointment of trustees_ 

The current trustees were co-opted as the first trustees of the charity.  Apart from the first charity trustees, every trustee must be appointed for a term of three years by a resolution passed at a properly convened meeting of the charity trustees.  In selecting individuals for appointment as charity trustees, the charity trustees must have regard to the skills, knowledge and experience needed for the effective oversight and administration of the CIO. 

None of the trustees has any beneficial interest in the company. 

All of the trustees are members of the charity and guarantee to contribute a maximum of £100 in the event of a winding up. 

The trustees' report was approved by the Board of Trustees. 

## Paul Stevens 

Paul Stevens **Trustee & Chair** 

29 July 2026 

- 4 - 



## **RAREMINDS CIO** 

## **STATEMENT OF TRUSTEES' RESPONSIBILITIES** 

## _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

The trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that year. 

In preparing these financial statements, the trustees are required to: 

- select suitable accounting policies and then apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgements and estimates that are reasonable and prudent; 

- state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in operation. 

The trustees are responsible for keeping sufficient accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

- 5 - 



## **RAREMINDS CIO** 

## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF RAREMINDS CIO** 

I report to the trustees on my examination of the financial statements of Rareminds CIO (the charity) for the year ended 31 December 2025. 

## **Responsibilities and basis of report** 

As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011. 

I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011. 

## **Independent examiner's statement** 

Since the charity’s gross income exceeded £250,000, the independent examiner must be a member of a body listed in section 145 of the Charities Act 2011. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. 

Your attention is drawn to the fact that the charity has prepared the financial statements in accordance with the relevant version of the Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. I understand that this has been done in order for the financial statements to provide a true and fair view in accordance with UK Generally Accepted Accounting Practice. 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

- 1 accounting records were not kept in respect of the charity as required by section 130 of the Charities Act 2011. 

- 2 the financial statements do not accord with those records; or 

- 3 the financial statements do not comply with the applicable requirements concerning the form and content of financial statements set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the financial statements give a true and fair view, which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. 


## **Gary Howard FCA** 

Howard Wilson Chartered Accountants 36 Crown Rise Watford Hertfordshire WD25 0NE 10 August 2026 

- 6 - 



## **RAREMINDS CIO** 

## **STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT** 

## _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

|**Current financial year**<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2025**<br>**2025**<br>**Year**<br>**Year**<br>**Notes**<br>**£**<br>**£**<br>**Income from:**<br>Voluntary income<br>**3**<br>41,244<br>-<br>Charitable activities<br>**4**<br>335,563<br>19,198<br>Investments<br>**5**<br>522<br>-<br>**Total income**<br>377,329<br>19,198<br>**Expenditure on:**<br>Fundraising and publicity<br>**6**<br>702<br>149<br>Charitable activities<br>**7**<br>302,756<br>12,079<br>**Total expenditure**<br>303,458<br>12,228<br>**Net income**<br>73,871<br>6,970<br>Transfers between funds<br>16,921<br>(16,921)<br>**Net movement in funds**<br>**8**<br>90,792<br>(9,951)<br>**Reconciliation of funds:**<br>Fund balances at 1 January 2025<br>32,485<br>20,619<br>**Fund balances at 31 December 2025**<br>123,277<br>10,668|**Total**<br>**2025**<br>**Year**<br>**15**<br>**£**<br>41,244<br>354,761<br>522<br>396,527<br>851<br>314,835<br>315,686<br>80,841<br>-<br>80,841<br>53,104<br>133,945|**Total**<br>**2024**<br>**months**<br>**£**<br>5,000<br>301,441<br>212|
|---|---|---|
|||306,653|
|||12,567<br>263,810|
|||276,377|
|||30,276<br>-|
|||30,276<br>22,828|
|||53,104|



The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. 

- 7 - 



## **RAREMINDS CIO** 

## **STATEMENT OF FINANCIAL ACTIVITIES (CONTINUED) INCLUDING INCOME AND EXPENDITURE ACCOUNT** 

## _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

|**Prior financial year**<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2024**<br>**2024**<br>**15 months**<br>**15 months**<br>**15**<br>**Notes**<br>**£**<br>**£**<br>**Income from:**<br>Voluntary income<br>**3**<br>-<br>5,000<br>Charitable activities<br>**4**<br>282,863<br>18,578<br>Investments<br>**5**<br>212<br>-<br>**Total income**<br>283,075<br>23,578<br>**Expenditure on:**<br>Fundraising and publicity<br>**6**<br>12,567<br>-<br>Charitable activities<br>**7**<br>260,851<br>2,959<br>**Total expenditure**<br>273,418<br>2,959<br>**Net income and movement in funds**<br>9,657<br>20,619<br>**Reconciliation of funds:**<br>Fund balances at 1 January 2024<br>22,828<br>-<br>**Fund balances at 31 December 2024**<br>32,485<br>20,619|**Total**<br>**2024**<br>**months**<br>**£**<br>5,000<br>301,441<br>212|
|---|---|
||306,653|
||12,567<br>263,810|
||276,377|
||30,276<br>22,828|
||53,104|



- 8 - 



## **RAREMINDS CIO** 

## **BALANCE SHEET** 

## _**AS AT 31 DECEMBER 2025**_ 

|**Notes**<br>**Current assets**<br>Debtors<br>**12**<br>Cash at bank and in hand<br>**Creditors: amounts falling due within**<br>**one year**<br>**13**<br>**Net current assets**<br>**The funds of the charity**<br>Restricted income funds<br>**16**<br>Unrestricted funds<br>**17**|**2025**<br>**£**<br>16,968<br>123,437<br>140,405<br>(6,460)|**£**<br>133,945<br>10,668<br>123,277<br>133,945|**2024**<br>**£**<br>35,780<br>62,840<br>98,620<br>(45,516)|**£**<br>53,104|
|---|---|---|---|---|
|||||20,619<br>32,485|
|||||53,104|



The financial statements were approved by the trustees on 29 July 2026 

Paul Stevens Paul Stevens Michael Hartnett **Trustee Trustee** 

## Michael Hartnett 

- 9 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **1 Accounting policies** 

## **Charity information** 

Rareminds CIO is a Charitable Incorporated Organisation. 

## **1.1 Basis of preparation** 

The financial statements have been prepared in accordance with the charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The charity is a Public Benefit Entity as defined by FRS 102. 

The charity has taken advantage of the provisions in the SORP for charities not to prepare a statement of cash flows. 

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn. 

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £. 

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below. 

## **1.2 Going concern** 

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements. 

## **1.3 Charitable funds** 

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives. 

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. 

Endowment funds are subject to specific conditions by donors that the capital must be maintained by the charity. 

## **1.4 Income** 

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. 

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. 

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset. 

- 10 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **1 Accounting policies** 

**(Continued)** 

## **1.5 Expenditure** 

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably. 

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use. 

## **1.6 Cash and cash equivalents** 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

## **1.7 Financial instruments** 

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. 

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument. 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 

## _**Basic financial assets**_ 

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. 

## _**Basic financial liabilities**_ 

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. 

## _**Derecognition of financial liabilities**_ 

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled. 

- 11 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **1 Accounting policies** 

## **(Continued)** 

## **1.8 Employee benefits** 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received. 

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits. 

## **1.9 Retirement benefits** 

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due. 

## **2 Critical accounting estimates and judgements** 

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. 

## **3 Income from voluntary income** 

|**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2025**<br>**2025**<br>**Year**<br>**Year**<br>**£**<br>**£**<br>Donations and gifts<br>6,244<br>-<br>Grants<br>35,000<br>-<br>41,244<br>-<br>**Grants**<br>Parexel MMS Europe<br>Limited<br>25,000<br>-<br>Takeda UK Limited<br>5,000<br>-<br>Amicus Therapeutics UK<br>Operations Limited<br>5,000<br>-<br>35,000<br>-|**Total**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**funds**<br>**funds**<br>**2025**<br>**2024**<br>**2024**<br>**2024**<br>**Year**<br>**15 months**<br>**15 months**<br>**15 months**<br>**£**<br>**£**<br>**£**<br>**£**<br>6,244<br>-<br>5,000<br>5,000<br>35,000<br>-<br>-<br>-<br>41,244<br>-<br>5,000<br>5,000<br>25,000<br>-<br>-<br>-<br>5,000<br>-<br>-<br>-<br>5,000<br>-<br>-<br>-<br>35,000<br>-<br>-<br>-|**Total**<br>**Unrestricted**<br>**Restricted**<br>**Total**<br>**funds**<br>**funds**<br>**2025**<br>**2024**<br>**2024**<br>**2024**<br>**Year**<br>**15 months**<br>**15 months**<br>**15 months**<br>**£**<br>**£**<br>**£**<br>**£**<br>6,244<br>-<br>5,000<br>5,000<br>35,000<br>-<br>-<br>-<br>41,244<br>-<br>5,000<br>5,000<br>25,000<br>-<br>-<br>-<br>5,000<br>-<br>-<br>-<br>5,000<br>-<br>-<br>-<br>35,000<br>-<br>-<br>-|
|---|---|---|
|||5,000|
|||-<br>-<br>-|
|||-|



- 12 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **4 Income from charitable activities** 

|**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2025**<br>**2025**<br>**£**<br>**£**<br>**Charitable activities**<br>Clinical services income<br>301,401<br>-<br>Consultancy income<br>34,162<br>-<br>Performance related<br>grants<br>-<br>19,198<br>335,563<br>19,198|**Total**<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2025**<br>**2024**<br>**2024**<br>**£**<br>**£**<br>**£**<br>301,401<br>233,959<br>-<br>34,162<br>48,904<br>-<br>19,198<br>-<br>18,578<br>354,761<br>282,863<br>18,578|**Total**<br>**2024**<br>**£**<br>233,959<br>48,904<br>18,578|
|---|---|---|
|||301,441|



## **Performance related grants analysis** 

||**Charitable**|**Charitable**|
|---|---|---|
||**activities**|**activities**|
||**2025**|**2024**|
||**£**|**£**|
|National Lottery|-|18,578|
|Vertex Pharmaceuticals|4,538|-|
|Blueprint Medicine|7,500|-|
|Kyowa Kirin|3,500|-|
|Chiesi|3,660|-|
||19,198|18,578|



## **5 Income from investments** 

||**Unrestricted**|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2025**|**2024**|
||**Year**|**15 months**|
||**£**|**£**|
|Interest receivable|522|212|



- 13 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **6 Expenditure on fundraising and publicity** 

||**Unrestricted**|**Restricted**|**Total**|**Unrestricted**|**Restricted**|**Total**|
|---|---|---|---|---|---|---|
||**funds**|**funds**||**funds**|**funds**||
||**2025**|**2025**|**2025**|**2024**|**2024**|**2024**|
||**Year**|**Year**|**Year**|**15 months**|**15 months**|**15 months**|
||**£**|**£**|**£**|**£**|**£**|**£**|
|**Fundraising and publicity**|||||||
|Fundraising and publicity|702|149|851|12,567|-|12,567|



## **7 Expenditure on charitable activities** 

|||**Charitable**|**Charitable**|
|---|---|---|---|
|||**activities**|**activities**|
|||**2025**|**2024**|
|||**Year**|**15 months**|
|||**£**|**£**|
||**Direct costs**|||
||Staff costs|108,979|-|
||Clinicians and supervision fees|185,860|187,569|
||Website costs|4,882|6,274|
||Development costs|-|26,212|
||Professional and consultancy fees|857|35,485|
||Office costs|7,983|3,998|
||Insurance|1,620|1,029|
||Training|2,494|1,879|
||Governance costs|2,160|1,364|
|||314,835|263,810|
||**Analysis by fund**|||
||Unrestricted funds|302,756|260,851|
||Restricted funds|12,079|2,959|
|||314,835|263,810|
|**8**|**Net movement in funds**|**2025**|**2024**|
|||**£**|**£**|
||The net movement in funds is stated after charging/(crediting):|||
||Fees payable for the independent examination of the charity's financial|||
||statements|2,160|1,364|



## **9 Trustees** 

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year. 

- 14 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **10 Employees** 

The average monthly number of employees, including trustees, during the year was: 

|Trustees<br>Senior Management Team<br>Total<br>**Employment costs**<br>Wages and salaries<br>Other pension costs<br>There were no employees whose annual remuneration was more than £60,000.<br>**Remuneration of key management personnel**<br>The remuneration of key management personnel was as follows:<br>Aggregate compensation|**2025**<br>**Number**<br>4<br>3<br>7<br>**2025**<br>**£**<br>106,681<br>2,298<br>108,979<br>**2025**<br>**£**<br>108,979|**2024**<br>**Number**<br>4<br>-|
|---|---|---|
|||4|
|||**2024**<br>**£**<br>-<br>-|
|||-|
|||**2024**<br>**£**<br>-|



## **11 Taxation** 

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes. 

## **12 Debtors** 

|**Debtors**|||
|---|---|---|
||**2025**|**2024**|
|**Amounts falling due within one year:**|**£**|**£**|
|Trade debtors|16,968|35,780|



- 15 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

|**13**<br>**Creditors: amounts falling due within one year**<br>**2025**<br>**Notes**<br>**£**<br>Deferred income<br>**14**<br>-<br>Trade creditors<br>3,797<br>Other creditors<br>503<br>Accruals<br>2,160<br>6,460<br>**14**<br>**Deferred income**<br>**2025**<br>**£**<br>Other deferred income<br>-<br>Deferred income is included in the financial statements as follows:<br>**2025**<br>**£**<br>Deferred income is included within:<br>Current liabilities<br>-<br>**2025**<br>**£**<br>Movements in the year:<br>Deferred income at 1 January 2025<br>30,000<br>Released from previous periods<br>(30,000)<br>Resources deferred in the year<br>-<br>Deferred income at 31 December 2025<br>-<br>**15**<br>**Retirement benefit schemes**<br>**2025**<br>**Defined contribution schemes**<br>**£**<br>Charge to profit or loss in respect of defined contribution schemes<br>2,298|**2024**<br>**£**<br>30,000<br>14,742<br>-<br>774|
|---|---|
||45,516|
||**2024**<br>**£**<br>30,000|
||**2024**<br>**£**<br>30,000|
||**2024**<br>**£**<br>-<br>-<br>30,000|
||30,000|
||**2024**<br>**£**<br>-|



The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund. 

- 16 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **16 Restricted funds** 

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used. 

||**At 1 January**|**Incoming**|**Resources**|**Transfers**|**At 31**|
|---|---|---|---|---|---|
||**2025**|**resources**|**expended**||**December**|
||||||**2025**|
||**£**|**£**|**£**|**£**|**£**|
|National Lottery - Wales|7,913|-|(700)|(6,704)|509|
|National Lottery - England|7,706|-|(349)|(7,307)|50|
|Takeda|5,000|-|-|(5,000)|-|
|Recordati Rare Diseases UK|-|-|-|2,090|2,090|
|Vertex Pharmaceuticals|-|4,538|(3,499)|-|1,039|
|Blueprint Medicine|-|7,500|(1,897)|-|5,603|
|Kyowa Kirin International|-|3,500|(3,036)|-|464|
|Chiesi|-|3,660|(2,747)|-|913|
||20,619|19,198|(12,228)|(16,921)|10,668|
|**Previous year:**|**At 1 January**|**Incoming**|**Resources**|**Transfers**|**At 31**|
||**2024**|**resources**|**expended**||**December**|
||||||**2024**|
||**£**|**£**|**£**|**£**|**£**|
|National Lottery - Wales|-|9,393|(1,480)|-|7,913|
|National Lottery - England|-|9,185|(1,479)|-|7,706|
|Takeda|-|5,000|-|-|5,000|
||-|23,578|(2,959)|-|20,619|



National Lottery Wales was funding for rare disease mental health and wellbeing resources for people impacted by a rare condition living in Wales (including translations). 

National Lottery England was funding for online mental health workshops and resources for people impacted by rare conditions living in England. 

Recordati Rare Diseases UK was funding for service work for two workshops. 

Vertex Pharmaceuticals,  Blueprint Medicine, Kyowa Kirin International and Chiesi are funding for phase 3 of the Rareminds Wellbeing Hub to provide free online mental health resources for people impacted by rare conditions. 

- 17 - 



## **RAREMINDS CIO** 

## **NOTES TO THE  FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 31 DECEMBER 2025**_ 

## **17 Unrestricted funds** 

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes. 

|**At 1**<br>General funds<br>**Previous year:**<br>**At 1**<br>General funds|**January**<br>**2025**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**Transfers**<br>**At 31**<br>**December**<br>**2025**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>32,485<br>377,329<br>(303,458)<br>16,921<br>123,277<br>**January**<br>**2024**<br>**Incoming**<br>**resources**<br>**Resources**<br>**expended**<br>**Transfers**<br>**At 31**<br>**December**<br>**2024**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>22,828<br>283,075<br>(273,418)<br>-<br>32,485|
|---|---|



## **18 Analysis of net assets between funds** 

|**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2025**<br>**2025**<br>**£**<br>**£**<br>**At 31 December 2025:**<br>Current assets/(liabilities)<br>123,277<br>10,668<br>123,277<br>10,668<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2024**<br>**2024**<br>**£**<br>**£**<br>**At 31 December 2024:**<br>Current assets/(liabilities)<br>32,485<br>20,619<br>32,485<br>20,619|**Total**<br>**2025**<br>**£**<br>133,945|
|---|---|
||133,945|
||**Total**<br>**2024**<br>**£**<br>53,104|
||53,104|



## **19 Related party transactions** 

There were no disclosable related party transactions during the year (2024 - none). 

- 18 - 

